Table of Contents Categories
  Encyclosphere.org ENCYCLOREADER
  supported by EncyclosphereKSF

Translational Genomics Research Institute

Topic: Organization

 From HandWiki - Reading time: 2 min
Short description: Research institute

A non-profit genomics research institute.

[ ⚑ ] 33°27′10.68″N 112°4′1.83″W / 33.4529667°N 112.067175°W / 33.4529667; -112.067175

Translational Genomics Research Institute
TypeResearch Institute
IndustryGenomics
FoundedJuly 2002, Phoenix, Arizona, United States
HeadquartersPhoenix, Arizona, United States
Key people
Jeffrey Trent
Revenue
  • Increase$51.7 million (2007)[1]
  • $18.3 million (2003)[1]
Number of employees
258 (2008)[1]
Websitewww.tgen.org
The Translational Genomics Research Institute at night

The Translational Genomics Research Institute (TGen)

is a non-profit genomics research institute based in Phoenix, Arizona, United States.

History and activities

TGen was established in July 2002 by Jeffrey Trent in Phoenix, Arizona, with an initial investment of US$100 million from Arizona public and private-sector investors.[1]

The field of translational genomics research searches for ways to apply results from the Human Genome Project to the development of improved diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes and other complex diseases.

The mission of TGen is to make and translate genomic discoveries into advances in human health.[2] TGen has contributed to the growth of scientific research and biotechnology in Arizona. The institute has been involved in collaborations and studies, such as the research on chronic traumatic encephalopathy (CTE) in former NFL players in partnership with Exosome Sciences.

TGen Administration

  • Jeffrey M. Trent, Ph.D., President & Scientific Director[1]
  • Sunil Sharma, MD FACP, Deputy Director
  • Michael Bassoff, President, TGen Foundation
  • Daniel Von Hoff, M.D., F.A.C.P., Executive Vice President, Physician-in-Chief[2]
  • Tess Burleson, MBA, CPA, Chief Operating Officer and President, TGen Accelerators
  • Chuck Coleson, Chief Financial Officer
  • Galen Perry, Vice President, Marketing and Communications
  • Brady Young, Vice President, Human Resources
  • Kendall Van Keuren-Jensen, co-Director[3]

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 Alltucker, Ken (16 April 2008). "5-year-old TGen fights for funding". The Arizona Republic. http://www.azcentral.com/business/articles/2008/04/16/20080416biz-tgenfund0416.html. 
  2. ↑ 2.0 2.1 Alltucker, Ken (16 April 2008). "Cancer-drug trials show promise". The Arizona Republic. http://www.azcentral.com/business/articles/2008/04/16/20080416biz-tgenfund0416side.html. 
  3. ↑ "Exosome Sciences, TGen to Launch Study of CTE in Former NFL Players". CellOMICs. 26 March 2018. https://www.clinicalomics.com/articles/exosome-diagnostics-tgen-to-launch-study-of-cte-in-former-nfl-players/1551. 

External links



Retrieved from "https://handwiki.org/wiki/index.php?title=Organization:Translational_Genomics_Research_Institute&oldid=3396953"
Licensed under CC BY-SA 3.0 | Source: https://handwiki.org/wiki/Organization:Translational_Genomics_Research_Institute
1 | Status: cached on September 26 2024 05:43:03
↧ Download this article as ZWI file
Encyclosphere.org EncycloReader is supported by the EncyclosphereKSF